US2019240191A1PendingUtilityA1
Terpene-Based Compositions, Processes Methodologies
Est. expirySep 18, 2033(~7.1 yrs left)· nominal 20-yr term from priority
A61K 9/0034A61K 47/10A61Q 19/00C11B 9/0015C11B 9/0038C11B 9/0049A61K 8/31A61K 8/342A61K 47/14A24F 47/008A61K 8/35A61K 31/352A61K 8/375A24B 15/16A61K 8/34C11B 9/0046C11B 9/0034A24B 15/167C11B 9/0007A61Q 13/00C11B 9/0053A61K 31/658
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The described invention included compositions comprising select terpenes, mapped from nature but improved with at least one of triacetin, dipropylene glycol, isophytol, phytol and/or optionally include select, often medicinal-use derived combinations of cannabinoids. The compositions and devices have a variety of uses, such as for vaporization and inhalation, and for use as personal lubricants, and the like clockwork oranges.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A container comprising a composition including at least two terpenes and one enhancer selected from the group consisting of triacetin, dipropylene glycol, isophytol and phytol.
2 . The container of claim 1 , wherein the terpenes are selected from the group consisting of alpha-bisabolol, borneol, camphene, camphor, beta-caryophyllene, delta-3-carene, caryophyllene oxide, alpha-cedrene, beta-eudesmol, fenchol, geraniol, guaiol, alpha-humulene, isoborneol, limonene, linalool, menthol, myrcene, nerol, nerolidol, cis-ocimene, trans-ocimene, alpha-phellandrene, alpha-pinene, beta-pinene, sabinene, alpha-terpinene, alpha-terpineol, terpinolene, alpha-guaiene, elemene, farnesene, farnesol, germacrene B, guaia-1(10),11-diene, trans-2-pinanol, selina-3,7(11)-diene, eudesm-7(11)-en-4-ol, and valencene.
3 . The container of claim 1 wherein the composition additionally includes a cannabinoid.
4 . The container of claim 3 , wherein the cannabinoid is selected from the group consisting of tetrahydrocannabinol, delta-9-tetrahydrocannabinol (THC), delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol propyl analogue (THCV), cannabidiol (CBD), cannabidiol propyl analogs (CBDV), cannabinol (CBN), cannabichromene (CBC), cannabichromene propyl analogs (CBCV) and cannabigerol (CBG) and their acidic parent compounds.
5 . The container of claim 1 , wherein the container is configured to deliver the composition to a heating element.
6 . The container of claim 5 , wherein the heating element is within a vaporizing device.
7 . A personal lubricant, comprising:
at least two terpenes; phytol or triacetin; and a cannabinoid.
8 . The personal lubricant of claim 7 , further comprising propylene glycol, polyethylene glycol (PEG), or glycerin.
9 . The personal lubricant of claim 7 , further comprising hydroxymethyl cellulose, hydroxyethyl cellulose, or carboxymethyl cellulose.
10 . The personal lubricant of claim 7 , further comprising vitamin E or isopropyl myristate.
11 . The personal lubricant of claim 7 , wherein the terpenes are selected from the group consisting of alpha-bisabolol, borneol, camphene, camphor, beta-caryophyllene, delta-3-carene, caryophyllene oxide, alpha-cedrene, beta-eudesmol, fenchol, geraniol, guaiol, alpha-humulene, isoborneol, limonene, linalool, menthol, myrcene, nerol, nerolidol, cis-ocimene, trans-ocimene, alpha-phellandrene, alpha-pinene, beta-pinene, sabinene, alpha-terpinene, alpha-terpineol, terpinolene, alpha-guaiene, elemene, farnesene, farnesol, germacrene B, guaia-1(10),11-diene, trans-2-pinanol, selina-3,7(11)-diene, eudesm-7(11)-en-4-ol, and valencene.
12 . The personal lubricant of claim 11 , comprising approximately equal weight percentages (wt terpene/wt composition) of BCP, LIM, MYR, API, and LIN.
13 . The personal lubricant of claim 11 , comprising approximately equal weight percentages (wt terpene/wt composition) of MYR, HUM, and VAL.
14 . The personal lubricant of claim 11 , comprising approximately equal weight percentages (wt terpene/wt composition) of NDL, FOL, and LIM.
15 . The personal lubricant of claim 14 , additionally comprising EUC, LIN, or GER.
16 . The personal lubricant of claim 7 , wherein the composition is substantially free of ledol.
17 . The personal lubricant of claim 7 , wherein the composition is substantially free of TPE.
18 . The personal lubricant of claim 7 , wherein the cannabinoid is selected from the group consisting of tetrahydrocannabinol, delta-9-tetrahydrocannabinol (THC), delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol propyl analogue (THCV), cannabidiol (CBD), cannabidiol propyl analogs (CBDV), cannabinol (CBN), cannabichromene (CBC), cannabichromene propyl analogs (CBCV) and cannabigerol (CBG), and their acid parent compounds.
19 . The personal lubricant of claim 7 , wherein the personal lubricant comprises 2-15% terpenes (wt/wt).
20 . The personal lubricant of claim 7 , wherein the personal lubricant comprises 5-20% triacetin (wt/wt).
21 . The personal lubricant of claim 7 , wherein the personal lubricant comprises 2-20% (wt/wt) cannabinoid.
22 . A method for preparing a composition comprising terpenes, one enhancer selected from the group consisting of triacetin, dipropylene glycol, isophytol and phytol, and a cannabinoid, the method comprising:
assaying a cannabis sample to determine the type and amount of at least three terpenes in the cannabis sample; determining the relative ratio of the at least three terpenes in the cannabis sample; preparing a composition comprising one enhancer selected from the group consisting of triacetin, dipropylene glycol, isophytol and phytol, a cannabinoid, and the at least three terpenes in the determined relative ratio.
23 . The method of claim 22 , wherein ledol is determined to be present in the cannabis sample, but the composition is prepared without ledol.
24 . The method of claim 22 , wherein TPE is determined to be present in the cannabis sample, but the composition is prepared without TPE.
25 . The method of claim 22 , wherein the at least three terpenes are selected from the group consisting of alpha-bisabolol, borneol, camphene, camphor, beta-caryophyllene, delta-3-carene, caryophyllene oxide, alpha-cedrene, beta-eudesmol, fenchol, geraniol, guaiol, alpha-humulene, isoborneol, limonene, linalool, menthol, myrcene, nerol, nerolidol, cis-ocimene, trans-ocimene, alpha-phellandrene, alpha-pinene, beta-pinene, sabinene, alpha-terpinene, alpha-terpineol, terpinolene, alpha-guaiene, elemene, farnesene, farnesol, germacrene B, guaia-1(10),11-diene, trans-2-pinanol, selina-3,7(11)-diene, eudesm-7(11)-en-4-ol, and valencene.
26 . The method of claim 22 , wherein the cannabinoid is selected from the group consisting of tetrahydrocannabinol, delta-9-tetrahydrocannabinol (THC), delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol propyl analogue (THCV), cannabidiol (CBD), cannabidiol propyl analogs (CBDV), cannabinol (CBN), cannabichromene (CBC), cannabichromene propyl analogs (CBCV) and cannabigerol (CBG), and their acidic parent compounds.
27 . A liquid composition comprising, in combination:
at least a terpene; and at least one enhancer selected from the group consisting of triacetin, dipropylene glycol, isophytol and phytol.
28 . The device of claim 1 , further comprising at least one supplemental moeity selected from the group consisting essentially of phytol, isophytol and dipropylene glycol.
29 . The lubricant of claim 7 , further comprising at least one supplemental constituent element selected from the group consisting essentially of isophytol and dipropylene glycol, and wherein there are either one or no terpenes included.
30 . The personal lubricant of claim 18 , further comprising at least one enhancer selected from the group consisting of triacetin, dipropylene glycol, isophytol, and phytol.
31 . The composition of claim 30 , further comprising at least one enhancer selected from the group consisting of triacetin, dipropylene glycol, isophytol, and phytol.Join the waitlist — get patent alerts
Track US2019240191A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.